1. Pasinetti GM, Eberstein JA. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease. J Neurochem. (2008) 106:1503–14. doi: 10.1111/j.1471-4159.2008.05454.x
2. Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, et al. Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement Geriatr Cogn Disord. (2006) 22:99–107. doi: 10.1159/000093478
3. Fitzpatrick S, Gilbert S, Serpell L. Systematic review: are overweight and obese individuals impaired on behavioural tasks of executive functioning? Neuropsychol Rev. (2013) 23:138–56. doi: 10.1007/s11065-013-9224-7
4. Pan A, Sun Q, Czernichow S, Kivimaki M, Okereke OI, Lucas M, et al. Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes. (2005) (2012) 36:595–602. doi: 10.1038/ijo.2011.111
5. Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes. (2005) (2010) 34:407–19. doi: 10.1038/ijo.2009.252
6. Buchenauer T, Behrendt P, Bode FJ, Horn R, Brabant G, Stephan M, et al. Diet- induced obesity alters behavior as well as serum levels of corticosterone in F344 rats. Physiol Behav. (2009) 98:563–9. doi: 10.1016/j.physbeh.2009.09.003
7. Yaseen A, Shrivastava K, Zuri Z, Hatoum OA, Maroun M. Prefrontal oxytocin is involved in impairments in prefrontal plasticity and social memory following acute exposure to high fat diet in juvenile animals. Cerebral Cortex. (2019) 29:1900–9. doi: 10.1093/cercor/bhy070
8. Takase K, Tsuneoka Y, Oda S, Kuroda M, Funato H. High-fat diet feeding alters olfactory-, social-, and reward-related behaviors of mice independent of obesity. Obesity. (2016) 24:886–94. doi: 10.1002/oby.21441
9. Zemdegs J, Quesseveur G, Jarriault D, Penicaud L, Fioramonti X, Guiard BP. High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice. British J Pharmacol. (2016) 173:2095–110. doi: 10.1111/bph.13343
10. Lee HJ, Macbeth AH, Pagani JH, Young WS III. Oxytocin: the great facilitator of life. Prog Neurobiol. (2009) 88:127–51. doi: 10.1016/j.pneurobio.2009.04.001
11. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol. (1998) 10:881–95. doi: 10.1046/j.1365-2826.1998.00279.x
12. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. (2001) 81:629–83. doi: 10.1152/physrev.2001.81.2.629
13. Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, et al. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA. (2005) 102:16096–101. doi: 10.1073/pnas.0505312102
14. Dabrowska J, Hazra R, Guo JD, Dewitt S, Rainnie DG. Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis. Front Neurosci. (2013) 7:156. doi: 10.3389/fnins.2013.0 0156
15. Jurek B, Neumann ID. The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev. (2018) 98:1805–908. doi: 10.1152/physrev.00031.2017
16. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport. (2008) 19:951–5. doi: 10.1097/WNR.0b013e3283021ca9
17. Horie K, Inoue K, Suzuki S, Adachi S, Yada S, Hirayama T, et al. Oxytocin receptor knockout prairie voles generated by CRISPR/Cas9 editing show reduced preference for social novelty and exaggerated repetitive behaviors. Horm Behav. (2019) 111:60–9. doi: 10.1016/j.yhbeh.2018.10.011
18. Walum H, Young LJ. The neural mechanisms and circuitry of the pair bond. Nat Rev Neurosci. (2018) 19:643–54. doi: 10.1038/s41583-018- 0072-6
19. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT. Social amnesia in mice lacking the oxytocin gene. Nat Genet. (2000) 25:284–8. doi: 10.1038/77040
20. Raam T, McAvoy KM, Besnard A, Veenema AH, Sahay A. Hippocampal oxytocin receptors are necessary for discrimination of social stimuli. Nat Commun. (2017) 8:2001. doi: 10.1038/s41467-017-02173-0
21. Hitti FL, Siegelbaum SA. The hippocampal CA2 region is essential for social memory. Nature. (2014) 508:88–92. doi: 10.1038/nature13028
22. Chiang MC, Huang AJY, Wintzer ME, Ohshima T, McHugh TJ. A role for CA3 in social recognition memory. Behav Brain Res. (2018) 354:22–30. doi: 10.1016/j.bbr.2018.01.019
23. Ferguson JN, Aldag JM, Insel TR, Young LJ. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci. (2001) 21:8278–85. doi: 10.1523/JNEUROSCI.21-20-08278.2001
24. Viviani D, Charlet A, van den Burg E, Robinet C, Hurni N, Abatis M, et al. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science. (2011) 333:104–7. doi: 10.1126/science.1201043
25. Pobbe RL, Pearson BL, Defensor EB, Bolivar VJ, Young WS, 3rd, Lee HJ, et al. Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors. Horm Behav. (2012) 61:436–44. doi: 10.1016/j.yhbeh.2011.10.010
26. Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, Iwashiro N, et al. Mitigation of sociocommunicational deficits of autism through oxytocin- induced recovery of medial prefrontal activity: a randomized trial. JAMA Psychiat. (2014) 71:166–75. doi: 10.1001/jamapsychiatry.2013.3181
27. Watanabe T, Kuroda M, Kuwabara H, Aoki Y, Iwashiro N, Tatsunobu N, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. (2015) 138(Pt 11):3400–12. doi: 10.1093/brain/awv249
28. Hara Y, Ago Y, Higuchi M, Hasebe S, Nakazawa T, Hashimoto H, et al. Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism. Horm Behav. (2017) 96:130–6. doi: 10.1016/j.yhbeh.2017.09.013
29. Harony-Nicolas H, Kay M, du Hoffmann J, Klein ME, Bozdagi-Gunal O, Riad M, et al. Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat. eLife. (2017) 6:e18904. doi: 10.7554/eLife.18904
30. Park SH, Kim YJ, Park JC, Han JS, Choi SY. Intranasal oxytocin following uncontrollable stress blocks impairments in hippocampal plasticity and recognition memory in stressed rats. Int J Neuropsychopharmacol. (2017) 20:861–6. doi: 10.1093/ijnp/pyx061
31. Arletti R, Bertolini A. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci. (1987) 41:1725–30. doi: 10.1016/0024-3205(87)90600-X
32. Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, et al. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci. (2008) 27:1947–56. doi: 10.1111/j.1460-9568.2008.06184.x
33. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, et al. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci. (2009) 29:2259–71. doi: 10.1523/JNEUROSCI.5593-08.2009
34. Peters S, Slattery DA, Uschold-Schmidt N, Reber SO, Neumann ID. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology. (2014) 42:225–36. doi: 10.1016/j.psyneuen.2014.01.021
35. Guzman YF, Tronson Nc Fau - Jovasevic V, Jovasevic V Fau - Sato K, Sato K Fau - Guedea AL, Guedea Al Fau - Mizukami H, Mizukami H Fau - Nishimori K, et al. Fear-enhancing effects of septal oxytocin receptors. Nat Neurosci. (2013) 16:1185–87. doi: 10.1038/nn.3465
36. Camerino C. Low sympathetic tone and obese phenotype in oxytocin- deficient mice. Obesity. (2009) 17:980–4. doi: 10.1038/oby.2009.12
37. Blevins JE, Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Dis. (2013) 14:311–29. doi: 10.1007/s11154-013-9260-x
38. Blevins JE, Baskin DG. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: insights from rodents, nonhuman primates and humans. Physiol Behav. (2015) 152(Pt B):438–49. doi: 10.1016/j.physbeh.2015.05.023
39. Teng BL, Nikolova VD, Riddick NV, Agster KL, Crowley JJ, Baker LK, et al. Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology. (2016) 105:61–71. doi: 10.1016/j.neuropharm.2015.12.025
40. Ferrer-Perez C, Castro-Zavala A, Lujan MA, Filarowska J, Ballestin R, Minarro J, et al. Oxytocin prevents the increase of cocaine-related responses produced by social defeat. Neuropharmacology. (2019) 146:50–64. doi: 10.1016/j.neuropharm.2018.11.011
41. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. (2004) 3:287–302. doi: 10.1111/j.1601-1848.2004.00076.x
42. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, et al. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. (2004) 3:303–14. doi: 10.1111/j.1601-183X.2004.00071.x
43. Vogel-Ciernia A, Wood MA. Examining object location and object recognition memory in mice. Curr Protoc Neurosci. (2014) 69:8.31.1–17. doi: 10.1002/0471142301.ns0831s69
44. Yang M, Crawley JN. Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci. (2009) 48:8.24.1–12. doi: 10.1002/0471142301.ns0824s48
45. Hiroi R, Neumaier JF. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav Brain Res. (2006) 166:93–100. doi: 10.1016/j.bbr.2005.07.021
46. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. (1985) 85:367–70. doi: 10.1007/BF00428203
47. Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology. (2005) 177:245–55. doi: 10.1007/s00213-004-2048-7
48. Maejima Y, Rita RS, Santoso P, Aoyama M, Hiraoka Y, Nishimori K, et al. Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas. Neuroendocrinology. (2015) 101:35–44. doi: 10.1159/000371636
49. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging. (2011) 3:1169–77. doi: 10.18632/aging.100408
50. Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, et al. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology. (2006) 185:218–25. doi: 10.1007/s00213-005-0293-z
51. Zilkha N, Kuperman Y, Kimchi T. High-fat diet exacerbates cognitive rigidity and social deficiency in the BTBR mouse model of autism. Neuroscience. (2017) 345:142–54. doi: 10.1016/j.neuroscience.2016.01.070
52. Broadbear JH, Kabel D, Tracy L, Mak P. Oxytocinergic regulation of endogenous as well as drug-induced mood. Pharmacol Biochem Behav. (2014) 119:61–71. doi: 10.1016/j.pbb.2013.07.002
53. Leonzino M, Ponzoni L, Braida D, Gigliucci V, Busnelli M, Ceresini I, et al. Impaired approach to novelty and striatal alterations in the oxytocin receptor deficient mouse model of autism. Horm Behav. (2019) 114:104543. doi: 10.1016/j.yhbeh.2019.06.007
54. Okuyama T, Kitamura T, Roy DS, Itohara S, Tonegawa S. Ventral CA1 neurons store social memory. Science. (2016) 353:1536–41. doi: 10.1126/science.aaf7003
55. Parfitt GM, Nguyen R, Bang JY, Aqrabawi AJ, Tran MM, Seo DK, et al. bidirectional control of anxiety-related behaviors in mice: role of inputs arising from the ventral hippocampus to the lateral septum and medial prefrontal cortex. Neuropsychopharmacol. (2017) 42:1715–28. doi: 10.1038/npp.2017.56
56. Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. (2017) 2017:6871089. doi: 10.1155/2017/6871089
57. Zhang G, Bai H, Zhang H, Dean C, Wu Q, Li J, et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron. (2011) 69:523–35. doi: 10.1016/j.neuron.2010.12.036
58. Iwasaki Y, Kumari P, Wang L, Hidema S, Nishimori K, Yada T. Relay of peripheral oxytocin to central oxytocin neurons via vagal afferents for regulating feeding. Biochem Biophys Res Commun. (2019) 519:553–8. doi: 10.1016/j.bbrc.2019.09.039
59. Zhang G, Cai D. Circadian intervention of obesity development via resting- stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab. (2011) 301:E1004–12. doi: 10.1152/ajpendo.00196.2011
60. Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, et al. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol Psychiat. (2018) 23:115–22. doi: 10.1038/mp.2017.27
61. Cordner ZA, Tamashiro KL. Effects of high-fat diet exposure on learning & memory. Physiol Behav. (2015) 152(Pt B):363–71. doi: 10.1016/j.physbeh.2015.06.008
62. Havranek T, Zatkova M, Lestanova Z, Bacova Z, Mravec B, Hodosy J, et al. Intracerebroventricular oxytocin administration in rats enhances object recognition and increases expression of neurotrophins, microtubule- associated protein 2, and synapsin I. J Neurosci Res. (2015) 93:893–901. doi: 10.1002/jnr.23559
63. Popik P, Vetulani J, van Ree JM. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology. (1992) 106:71–4. Epub 1992/01/01. doi: 10.1007/BF02253591
64. Lin YT, Chen CC, Huang CC, Nishimori K, Hsu KS. Oxytocin stimulates hippocampal neurogenesis via oxytocin receptor expressed in CA3 pyramidal neurons. Nat Commun. (2017) 8:537. doi: 10.1038/s41467-017-00675-5
65. Tomizawa K, Iga N, Lu YF, Moriwaki A, Matsushita M, Li ST, et al. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci. (2003) 6:384–90. doi: 10.1038/nn1023
66. Uvnas-Moberg K, Ahlenius S Fau - Hillegaart V, Hillegaart V Fau - Alster P, Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav. (1994) 49:101–6. doi: 10.1016/0091-3057(94)90462-6
67. Grillon C, Krimsky M, Charney DR, Vytal K, Ernst M, Cornwell B. Cornwell, oxytocin increases anxiety to unpredictable threat. Mol Psychiatry. (2013) 18:958–60. doi: 10.1038/mp.2012.156
68. Wu H, Liu Q, Kalavagunta PK, Huang Q, Lv W, An X, et al. Normal diet vs high fat diet - a comparative study: behavioral and neuroimmunological changes in adolescent male mice. Metab Brain Dis. (2018) 33:177–90. doi: 10.1007/s11011-017-0140-z
69. Noack J, Richter K, Laube G, Haghgoo HA, Veh RW, Engelmann M. Different importance of the volatile and non-volatile fractions of an olfactory signature for individual social recognition in rats versus mice and short- term versus long-term memory. Neurobiol Learn Mem. (2010) 94:568–75. doi: 10.1016/j.nlm.2010.09.013
70. Freeman SM, Ngo J, Singh B, Masnaghetti M, Bales KL, Blevins JE. Effects of chronic oxytocin administration and diet composition on oxytocin and vasopressin 1a receptor binding in the rat brain. Neuroscience. (2018) 392:241–51. Epub 2018/08/03. doi: 10.1016/j.neuroscience.2018. 07.037
71. Insel TR, Winslow JT, Witt DM. Homologous regulation of brain oxytocin receptors. Endocrinology. (1992) 130:2602–8. doi: 10.1210/endo.130. 5.1315251
72. Mairesse J, Gatta E, Reynaert ML, Marrocco J, Morley-Fletcher S, Soichot M, et al. Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats. Psychoneuroendocrinology. (2015) 62:36–46. doi: 10.1016/j.psyneuen.2015.07.005
73. Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW. Oxytocin enhances hippocampal spike transmission by modulating fast- spiking interneurons. Nature. (2013) 500:458–62. doi: 10.1038/nature12330
74. Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS ONE. (2011) 6:e25565. doi: 10.1371/journal.pone.0025565
75. Ludwig M, Leng G. Intrahypothalamic vasopressin release. an inhibitor of systemic vasopressin secretion? Adv Exp Med Biol. (1998) 449:163–73. doi: 10.1007/978-1-4615-4871-3_19
76. Hicks C, Ramos L, Reekie TA, Narlawar R, Kassiou M, McGregor IS. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology. (2015) 232:2659–67. doi: 10.1007/s00213-015-3902-5
77. Frantz MC, Pellissier LP, Pflimlin E, Loison S, Gandia J, Marsol C, et al. LIT-001, the first nonpeptide oxytocin receptor agonist that improves social interaction in a mouse model of autism. J Med Chem. (2018) 61:8670–92. doi: 10.1021/acs.jmedchem.8b00697
論文の公開元へ
